vimarsana.com
Home
Live Updates
Arbutus Reports Third Quarter 2023 Financial Results and Provides Corporate Update : comparemela.com
Arbutus Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Multiple data presentations upcoming at AASLD – The Liver Meeting®, including preliminary data from Phase 2a clinical trial combining imdusiran, our RNAi therapeutic, with VTP-300, an HBV...
Related Keywords
Canada ,
United States ,
Canadian ,
William Collier ,
Barinthus Bio ,
N Acetylgalactosamine Galnac ,
Michaelj Mcelhaugh ,
Lisam Caperelli ,
Securities Exchange ,
Company Board Of Directors ,
Arbutus Biopharma Corporation Nasdaq ,
Roivant Sciences Ltd ,
World Health Organization ,
Liver Meeting ,
Webcast Today ,
Biopharma Corporation ,
American Association ,
Liver Diseases ,
Chief Executive Officer ,
Arbutus Co Founder ,
Cash Equivalents ,
Months Ended September ,
Share Purchase ,
Open Market Sale ,
Looking Statements ,
Securities Act ,
Securities Exchange Act ,
Arbutu Annual Report ,
Arbutu Quarterly Reports ,
Markets ,
comparemela.com © 2020. All Rights Reserved.